Novartis

News

Kite claims a first for CAR-T Tecartus in adult leukaemia

The FDA has approved Kite Pharma's Tecartus as a treatment for adults with relapsed or refractory B-cell precursor acute lymphoblastic leukaemia (ALL), making CAR-T therapy an option for an

News

Novartis tightens up its COVID-19 vaccine policy for staff

Novartis has joined a growing number of companies insisting that its workforce is double vaccinated against COVID-19 if they want to work at one of its sites.

News

Novartis drug raises hope of tackling malaria drug resistanc...

More than two decades ago , Novartis made a big contribution to the fight against malaria when it won approval for Coartem, the first artemisinin-based combination therapy (ACT), which has

News

Roche builds evidence for Evrysdi's benefits in younger SMA ...

Roche has highlighted new data with its oral treatment for spinal muscular atrophy (SMA) – Evrysdi – showing its benefits when given to pre-symptomatic babies with the rare disease.

Sales & Marketing

Creating a successful and productive partnership

EFPIA: Partnership is the key to healthcare’s biggest challe...

The European pharma body’s new Health Collaboration Guide hopes to inspire greater partnership working across healthcare, showcasing award-winning collaborations involving Pfizer, Janssen,

News